Advanced Cancer Clinical Trials

There are 10 registered clinical trials for Advanced Cancer in the TrialLens index.

Trials (10)

• Study on Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignant Tumors Phase 1/2 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
• A Study of ARRY-334543 and Gemcitabine in Patients With Advanced Cancer and Pancreatic Cancer Phase 1/2 · Array BioPharma
• The Exceptional Patient in Cancer Care N/A · M.D. Anderson Cancer Center
• Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2) Phase 2 · I-Mab Biopharma US Limited
• A Phase 1 Study of LY2874455 in Participants With Advanced Cancer Phase 1 · Eli Lilly and Company
• A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer Phase 1 · Array Biopharma, now a wholly owned subsidiary of Pfizer
• Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab Phase 1/2 · RAPT Therapeutics, Inc., a member of the GSK plc group of companies
• The Feasibility of a Physical Activity Intervention for Advanced Multiple Myeloma Patients N/A · Dr. Nicole Culos-Reed
• Study of GNX102 in Patients With Advanced Solid Tumors Phase 1 · GlycoNex, Inc.
• Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers Phase 1 · Arcus Biosciences, Inc.

Related landscapes

• Phase 1/2 Advanced Cancer
• N/A Advanced Cancer
• Phase 2 Advanced Cancer
• Phase 1 Advanced Cancer

Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.